Autumn 2010 (Pdf)

Total Page:16

File Type:pdf, Size:1020Kb

Autumn 2010 (Pdf) The Genome Scientist UW Genome Sciences | www.gs.washington.edu | Volume 5 No 1 | Autumn 2010 Genome Sciences Welcomes Five New Faculty Members Dr. Elhanan Borenstein Dr. James Bruce Dr. Su-In Lee Dr. Judit Villen Dr. Alejandro Wolf-Yadlin The Genome Scientist is published by the Department of Genome Sciences at the University of Washington. For more information, please see our website, www.gs.washington.edu. NOTES FROM THE CHAIR What a time to be in Genome Sciences! The Along with our research, education continues to thrive at past two years have been an exciting, yet all levels. Our graduate program is exceptional. Incoming challenging time. students these past couple years have been simply outstand- ing; current students are publishing exciting papers; graduat- As you can see from the cover, we have ing students are securing excellent post-docs. Time to degree welcomed fi ve outstanding new faculty into is falling. In the undergraduate arena we are revamping our the Department – Elhanan Borestein, Jim basic genetics course. As part of this we have recruited Mi- Bob Waterston Bruce, Su-In Lee, Judit Villen, and Alejandro chelle Smith to join the faculty as a Lecturer. She comes from Wolf-Yadlin. They bring real strengths in a post-doctoral NSF sponsored teaching program at the Uni- computational biology and proteomics to what are already versity of Colorado and will help organize the revised genetics strong programs. The diversity of their backgrounds is strik- course. Celeste Berg and Bonnie Brewer have also created a ing, and they connect us with new areas intellectually, on “CSI-Seattle” course for a small group of incoming freshmen. campus and in the world. You can read more about them on In fact, the course staged a “murder” outside the building that pp. 6-7; suffi ce it to say here that we are excited by their arriv- the students solved using the latest and greatest DNA foren- als and expect great things from them in the coming years. sics. In addition, for the past two summers the Department has hosted a half-dozen or so undergraduates from across That we were able to add any new faculty in these tough the country for a ten-week research experience. The students economic times was itself exciting. In the fall of 2008, just as presented their posters to the Department over pizza and we were about to launch our search for new faculty, the Uni- their accomplishments were most impressive. Beyond these versity announced a hiring freeze, and as the recession took more traditional measures, the Department continues to off er hold in December, the University looked again at exceptions its summer public lecture series “Wednesday at the Genome” it had granted. Fortunately Genome Sciences was allowed to for the fourth year with 150-200 people attending each of go ahead, and we were rewarded with wonderful new hires. the 4 talks. In addition to all this, as you can read about on On the down side, the state has severely cut the University p. 12, Maureen Munn’s outreach program continues to bring budget with some devastating impacts on some departments. genome science into the high school classroom. We can only hope that the Governor and Legislature in future budgets recognize the critical role of the University in the The past couple years have also brought some changes to the future of the state. administration. In particular, Paula Kassos, who began with me in St. Louis in 1992, retired this past year. She married Dan On the science front, new technologies, particularly DNA James and has moved to North Carolina (but she still keeps in sequencing technologies, are revolutionizing our fi eld, open- touch through email). That left a big hole in the Department, ing whole new avenues of exploration. Fortuitously, the but we were fortunate to have Liz Lancaster as an interim NIH received almost $10B in ARRA (stimulus) funding in the director. In the middle of August, Nancy Cameron came on spring of 2009 just as the new technologies were building up board as director. Nancy comes to us from the Department steam. The result has been an explosion in the volume of new of Electrical Engineering and before that she worked in the genome sequences and in the ways in which DNA sequence central administration at the University of Oregon. Nancy can be used to assay biological function. The Department brings terrifi c administrative skills to us and we look forward was particularly well positioned to exploit this combination to working with her in the coming years to make this an ever of new technology and an infusion of funds. In conjunction better department. with the award of an NHLBI grant, the Northwest Genomics Center was created and is now in the process of sequencing This just scratches the surface of activities in Genome Sci- the protein-coding portions of thousands of patient genomes ences these past couple years. The combination of disciplines, by September, 2011. With the additional help of the Washing- ages and personalities has made Genome Sciences a hive of ton Research Foundation and the Washington’s Life Science activity. The faculty continue to receive recognition at all levels Discovery Fund, the Department now houses some 16 high (see pp. 4-5). Our impressive faculty interaction map, which throughput DNA sequencing instruments, producing the depicts the faculty as nodes and their shared projects, grants equivalent of a human genome sequence every hour – simply and papers as edges (courtesy of Bill Noble), grows ever more amazing! But beyond the sheer volume of data, the Depart- complex with collaborations bringing people together to ment has become a recognized leader in the creative appli- solve new problems. The Foege Building continues to be a joy, cation and analysis of these data sets (see pp. 8-10 for some with communal areas and the cafeteria facilitating interac- examples). Not only are we discovering new genes underlying tions and enough fl exible space to allow us to accommodate human disease, we are creating the knowledge base that will our new initiatives. Amazingly, in less than fi ve years we have enable us to understand eventually how yeast, worms, fl ies almost fi lled our half of the building! Please come by for a visit and mice work. With all the other wonderful science going on to see fi rst hand the remarkable energy and excitement. around here, the Department is pulsing with excitement! THE GENOME SCIENTIST 2 The Genome Scientist layout - Brian Giebel questions / comments - [email protected] NEWS & HONORS UW LAUNCHES NORTHWEST GENOMICS CENTER The National Heart, Lung, and Blood Institute (NHLBI) an- environment, and lifestyle choices, helping us bring the best nounced Oct. 1, 2009 that the University of Washington (UW) science to the patients who need it most,” said NHLBI Director will receive two of the six “Grand Opportunity”NHLBI Large- Dr. Elizabeth G. Nabel. Scale DNA Sequencing Project awards. The multi-institutional genomics project will examine the genetic connections to The Northwest Genomics Center in Seattle will be among the heart, lung, and blood diseases that account for three of the fi rst new, large-scale genomics centers focused entirely on leading causes of death in the United States. medical sequencing to be created in the United States in more than a decade. The UW also received $2 million in funding The research is co-funded by the National Institutes of Health from the state’s Life Sciences Discovery fund to support the (NIH) Director’s Offi ce. The two-year national project, at a total Center’s infrastructure. funding of $64 million, was made possible by the American Recovery and Reinvestment Act of 2009. “The Northwest Genomics Center will apply cutting edge, next generation sequencing technology to uncover the diff erences The UW will receive $25 million to launch the Northwest Ge- in our genetic code and explore how these may infl uence nomics Center, one of two sequencing centers for the project. traits, such as cholesterol and blood pressure, that impact The second sequencing center will be located at the Broad our risk for developing cardiovascular disease,”said Dr. Deb- Institute of MIT and Harvard in Cambridge, Mass. bie Nickerson, UW professor of genome sciences and one of the principal investigators for the new Center. Other principal The UW will also receive a $5.2 million grant, under the direc- investigators are Drs. Jay Shendure, Philip Green, and Mark tion of Dr. Michael Bamshad, UW professor of pediatrics in Rieder, who are also faculty members in the UW Department the Division of Genetic Medicine, to manage the lung disease of Genome Sciences. population research portion of the national project. Ohio State University, Washington University in St. Louis, and the Univer- “This is an extraordinary team eff ort to which we all bring sity of Virginia are the other participating institutions manag- individual expertise,”Nickerson said. She and Rieder are lead- ing cardiovascular and blood disease projects. ers in medical sequencing of cardiovascular, blood and lung diseases. Shendure is one of the pioneers in the development “This extraordinary collaboration promises to deepen our and application of next generation sequencing technology, understanding of the complex interactions of genetics, the and Green is a world leader in developing new software tools for sequence analysis, including the tools that helped to gen- erate the human genome sequence. Bamshad, who will head the lung disease component of the national project, is noted for his work on common genetic variations in the United States population and how these af- fect individual and ethnic group diff erences in susceptibility to disease.
Recommended publications
  • Current Positions
    Jay Shendure, MD, PhD Updated December 31, 2020 Current Positions Investigator, Howard Hughes Medical Institute Professor, Genome Sciences, University of Washington Director, Allen Discovery Center for Cell Lineage Director, Brotman Baty Institute for Precision Medicine Contact Information E-mail: [email protected] Lab website: http://krishna.gs.washington.edu Office phone: (206) 685-8543 Education • 2007 M.D., Harvard Medical School (Boston, Massachusetts) • 2005 Ph.D. in Genetics, Harvard University (Cambridge, Massachusetts) Research Advisor: George M. Church Thesis entitled “Multiplex Genome Sequencing and Analysis” • 1996 A.B., summa cum laude in Molecular Biology, Princeton University (Princeton, NJ) Research Advisor: Lee M. Silver Professional Experience • 2017 – present Scientific Director Brotman-Baty Institute for Precision Medicine • 2017 – present Scientific Director Allen Discovery Center for Cell Lineage Tracing • 2015 – present Investigator Howard Hughes Medical Institute • 2015 – present Full Professor (with tenure) Department of Genome Sciences, University of Washington, Seattle, WA • 2010 – present Affiliate Professor Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, WA • 2011 – 2015 Associate Professor (with tenure) Department of Genome Sciences, University of Washington, Seattle, WA • 2007 – 2011 Assistant Professor Department of Genome Sciences, University of Washington, Seattle, WA • 1998 – 2007 Medical Scientist Training Program (MSTP) Candidate Department of Genetics, Harvard Medical School, Boston, WA • 1997 – 1998 Research Scientist Vaccine Division, Merck Research Laboratories, Rahway, NJ • 1996 – 1997 Fulbright Scholar to India Department of Pediatrics, Sassoon General Hospital, Pune, India 1 Jay Shendure, MD, PhD Honors, Awards, Named Lectures • 2019 Richard Lounsbery Award (for extraordinary scientific achievement in biology & medicine) National Academy of Sciences • 2019 Jeffrey M. Trent Lectureship in Cancer Research National Human Genome Research Institute, National Institutes of Health • 2019 Paul D.
    [Show full text]
  • Summer 2005 (Pdf)
    T H E G E N O M E S C I E N T I S T Volume 2, Number 1 Summer 2005 DEPARTMENT ADDS THREE FACULTY MEMBERS Joshua Akey, Assistant Professor Joshua Akey, Ph.D., joined Genome Sciences last fall from the Fred Hutchinson Cancer Research Center where he had been a postdoctoral fellow in the Kruglyak Lab. Dr. Akey commented that “there were many features that attracted me to Genome Sciences, including the strength, breadth, and collegiality of the faculty and a strong graduate pro- gram.” Well known in the fields of population Evan Eichler, genetics and molecular evolution, Dr. Associate Professor Akey has research interests that include understanding how evolutionary forces Evan Eichler, shape patterns of genetic variation Ph.D., joined within and between species and how we Genome Sci- UW Genome Sciences www.gs.washington.edu continued on page 2 ences in May 2004 from , Case Western Michael MacCoss Reserve Uni- Assistant Professor versity, not- IN THIS ISSUE: Michael ing that “Ge- MacCoss, Ph.D., nome Sciences combines the strengths came to Ge- of a more traditional genetics program New Faculty 1-2 nome Sciences while taking advantage of new devel- Notes from the Chair 2 in December opments in genome technology and Fangman Symposium 3 2003 from the computer science. I am excited by the Foege Building 3 Scripps Insti- prospects – genomics with a strong Faculty Honors 4-5 tute, where he genetic backbone is poised to make News & Notes 6-7 had been a some of the most significant contribu- Research Highlights 8-12 postdoctoral fellow in the Yates Lab.
    [Show full text]
  • Autumn 2002 (Pdf)
    he Genome Scientist TUniversity of Washington Department of Genome Sciences Newsletter/Volume 1, Number 1/Fall 2002 Robert H. Waterston, M.D., Ph.D. to Chair the Department of Genome Sciences Dr. Robert H. Waterston will chair the recently formed Department of Genome Sciences and will hold the endowed William H. Gates III Chair in Biomedical Sciences. An innovator in genome research, Dr Waterston will lead the Department in exciting new areas. The goals of the Department are well matched to those of Dr. Waterston: bring together model organism biologists, computational biologists, and technology developers to speed the analysis needed to interpret the genome. “It’s a magnificent opportunity,” said Dr. Waterston. “They have marshaled the resources to make this a very strong program.” Stan Fields, Acting Chair, said, “We are tremendously excited...we will be able to hire new faculty and move into new areas of biology.” At 58, Bob Waterston is internationally recognized as a leader in genome sequencing and the International Human Genome Project. His awards include the 2002 International Gairdner Award for outstanding achieve- ment in biomedical research (see page 8), election to the National Academy of Sciences, the 2000 George W. Beadle Medal, the first Dan David Prize, and the Alfred P. Sloan Award. Dr. Waterston’s achievements in genome research began early on in his career. In the mid-80’s, together with John Sulston of the Sanger Centre, he proposed one of the largest scientific ventures ever attempted: the sequence of Caenorhabditis elegans, “the worm.” In the face of scientific skepticism Dr. Waterston forged ahead, creating the Genome Sequencing Center in St.
    [Show full text]
  • Autumn 2008 (Pdf)
    The GenomeSample Text Scientist Volume 4 Number 1 Autumn 2008 Genome Sciences Welcomes Three New Faculty Members www.gs.washington.edu UW Genome Sciences Dr. Maitreya Dunham Dr. Christine Queitsch Dr. Jay Shendure IN THIS ISSUE: Notes from the Chair 2 Faculty News & Honors 3-4 News & Notes 4-5 New Faculty Members 6-7 Research Highlights 8-9 Student News 10-15 The Genome Scientist is published by the Department of Genome Sciences at the University of Washington. For more information, please visit our website: www.gs.washington.edu the genome scientist 1 Not es From the Chair Genome Sciences is an excit- to identify a person’s individual (rare) mutations. Suc- ing place these days. Three cess here will drop costs to a few thousand dollars per new faculty members have person, opening the way to broad resequencing of cases joined us in the past year, and and controls. Josh Akey, working with Jay, Mike Mac- a fourth will arrive in Decem- Coss and Stan Fields, is analyzing 35 or more diff erent ber. Advances in technology yeast isolates to examine the impact of DNA sequence are opening new avenues to variation comprehensively on mRNAs, proteins and attack problems with a scope metabolites, a tour de force simply unfathomable a few and precision unimaginable years ago. John Stamatoyannopoulos is applying this even just a few years ago. Our next-generation sequencing technology to identify DNa- Bob Waterston new digs in the Foege Build- seI hypersensitive sites (regions of open chromatin) in ing are a delight. These factors genomes from yeast to human.
    [Show full text]
  • SULSTON Medical Research Council Laboratory of Molecular Biology and Wellcome Trust Sanger Institute, Cambridge, CB10, 1SA, United Kingdom
    C. elegans: THE CELL LINEAGE AND BEYOND Nobel Lecture, December 8, 2002 by JOHN E. SULSTON Medical Research Council Laboratory of Molecular Biology and Wellcome Trust Sanger Institute, Cambridge, CB10, 1SA, United Kingdom. Thank you so very much for inviting me to be here. It gives me a mingled sense – of humility at how much I owe to others, and of joy that the collective work on the worm has been recognised in this way. Among the first of my many mentors was my PhD supervisor, Colin Reese, who was developing non-aqueous methods for oligonucleotide synthesis (e.g. Fromageot et al., 1968). Colin passed me on to my postdoctoral supervisor Leslie Orgel at the Salk Institute, to work on prebiotic chemistry. The plan was to see to what extent we could copy RNA chains without enzymes. The products were in low yield, and the challenge was to work out the sequences that had been produced. We used cutting with different ribonucleases, and chromatography to separate the fragments (e.g. Sulston et al., 1968). My introduction to C. elegans came in 1969 with my move, at Leslie's sug- gestion, to Sydney Brenner's group at the Medical Research Council's Laboratory of Molecular Biology (Figure 1). Sydney was reputed to be setting Figure 1. Sydney Brenner, laboratory and Caernorhabditis elegans. Photo: MRC Laboratory of Molecular Biology. 363 up a group to work on the nervous system of a nematode, though at that point nobody knew much about it (Brenner, 1973). Sydney had already collected numerous mutations that affected the behav- iour of the worms (Brenner,1974), and one of my first projects was to investi- gate the level of glutamate decarboxylase in them, for GABA was believed to function as an inhibitory transmitter.
    [Show full text]
  • 2000 Thomas Hunt Morgan Medal
    Copyright 2001 by the Genetics Society of America The 2000 GSA Honors and Awards The Genetics Society of America annually honors members who have made outstanding contributions to genetics. The Thomas Hunt Morgan Medal recognizes a lifetime contribution to the science of genetics. The Genetics Society of America Medal recognizes particularly outstanding contributions to the science of genetics within the past ®fteen years. The George W. Beadle Medal recognizes distinguished service to the ®eld of genetics and the community of geneticists. We are pleased to announce the 2000 awards. The 2000 Thomas Hunt Morgan Medal Evelyn M. Witkin Evelyn M. Witkin HEN one meets Evelyn Witkin, one is struck both the ®eld and give it cohesion. Despite her extreme im- W by her intellectual boldness and her personal portance to this ®eld, if Evelyn herself were writing this modesty. From the beginning, Evelyn was propelled by perspective, it would be a bare-bones account indeed, a desire to answer big questions; her achievements are the very antithesis of a self-promotional document. a testimony to the power of that approach. Evelyn de- Evelyn's Ph.D. studies on induced mutagenesis imme- cided on graduate work in genetics because she felt it diately established her intellectual independence. Al- important to test Tro®m Lysenko's now largely discred- though working with Theodosius Dobzhansky, she ited ideas on how heredity could be altered by the envi- chose to use E. coli rather than Drosophila as her experi- ronment. After a few months of study, she realized that mental organism, having been in¯uenced by the 1943 his theory had no merit.
    [Show full text]
  • Joint Proclamation by the Heads of Government of Six Countries Regarding the Completion of the Human Genome Sequence
    Joint Proclamation by the Heads of Government of Six Countries Regarding the Completion of the Human Genome Sequence We, the Heads of Government of the United States of America, the United Kingdom, Japan, France, Germany, and China, are proud to announce that scientists from our six countries have completed the essential sequence of three billion base pairs of DNA of the human genome, the molecular instruction book of human life. Remarkable advances in genetic science and technology have been made in the five decades since the landmark discovery of the double-helix structure of DNA in April 1953. Now, in the very month and year of the 50th anniversary of that important discovery by Watson and Crick, the International Human Genome Sequencing Consortium has completed decoding all the chapters of the instruction book of human life. This information is now freely available to the world without constraints via public databases on the World Wide Web. This genetic sequence provides us with the fundamental platform for understanding ourselves, from which revolutionary progress will be made in biomedical sciences and in the health and welfare of humankind. Thus, we take today an important step toward establishing a healthier future for all the peoples of the globe, for whom the human genome serves as a common inheritance. We congratulate all the people who participated in this project on their creativity and dedication. Their outstanding work will be noted in the history of science and technology, and as well in the history of humankind, as a landmark achievement. We encourage the world to celebrate the scientific achievement of completing the Human Genome Project, and we exhort the scientific and medical communities to rededicate themselves to the utilization of these new discoveries to reduce human suffering.
    [Show full text]
  • The Bermuda Triangle: the Pragmatics, Policies, and Principles for Data Sharing in the History of the Human Genome Project
    Journal of the History of Biology (2018) 51:693–805 https://doi.org/10.1007/s10739-018-9538-7 The Bermuda Triangle: The Pragmatics, Policies, and Principles for Data Sharing in the History of the Human Genome Project 1,2 3 4 Kathryn Maxson Jones • Rachel A. Ankeny • Robert Cook-Deegan Published online: 2 November 2018 Ó The Author(s) 2018 Abstract The Bermuda Principles for DNA sequence data sharing are an enduring legacy of the Human Genome Project (HGP). They were adopted by the HGP at a strategy meeting in Bermuda in February of 1996 and implemented in formal policies by early 1998, mandating daily release of HGP-funded DNA sequences into the public domain. The idea of daily sharing, we argue, emanated directly from strategies for large, goal-directed molecular biology projects first tested within the ‘‘community’’ of C. elegans researchers, and were introduced and defended for the HGP by the nematode biologists John Sulston and Robert Waterston. In the C. elegans com- munity, and subsequently in the HGP, daily sharing served the pragmatic goals of quality control and project coordination. Yet in the HGP human genome, we also argue, the Bermuda Principles addressed concerns about gene patents impeding scientific advancement, and were aspirational and flexible in implementation and justification. They endured as an archetype for how rapid data sharing could be realized and rationalized, and permitted adaptation to the needs of various scientific communities. Yet in addition to the support of Sulston and Waterston, their adoption also depended on the clout of administrators at the US National Institutes of Health (NIH) and the UK nonprofit charity the Wellcome Trust, which together funded 90% of the HGP human sequencing effort.
    [Show full text]
  • Maynard Olson So, I'm Maynard Olson. I'm Professor Emeritus of Medicine
    NHGRI: Maynard Olson 1 3/24/17 Maynard Olson So, I’m Maynard Olson. I’m Professor Emeritus of Medicine and Genome Sciences at the University of Washington. And the Emeritus part is for real. I actually did retire a few years ago and spend very little time at the University of Washington and am involved in a variety of other activities, but not any longer active in research. And I grew up in Bethesda, on Edgemoor Lane, yes. I -- my father was an intramural NIH researcher in the -- what was then called the Division of Infectious Diseases. And at that time responsibilities had not sorted out between the CDC and the NIH to the degree that they have now, and most of my father’s work was more similar to what goes on now with the CDC than what goes on at the -- in the NIAID. But, in any event, I kind of grew up in this culture and left -- I was born here and left my senior year in high school but -- and -- to the west coast where I’ve spent a lot of my time since then. But, I went through the public school in Bethesda. Bethesda Elementary, the no longer extent Leland Junior High school and BCC. I can remember -- I can remember the NIH campus when I was a young child. Still rented some of the land to a neighboring farmer to graze cows on because the initial land gift here was larger than the NIH could put to scientific use at that time, and that was when the NIH, particularly to the north, was surrounded by farm land.
    [Show full text]
  • The Nobel Prize for Physiology Or Medicine 2002
    PublisherInfo PublisherName : BioMed Central PublisherLocation : London PublisherImprintName : BioMed Central The Nobel Prize for Physiology or Medicine 2002 ArticleInfo ArticleID : 4602 ArticleDOI : 10.1186/gb-spotlight-20021008-01 ArticleCitationID : gb-spotlight-20021008-01 ArticleSequenceNumber : 268 ArticleCategory : Research news ArticleFirstPage : 1 ArticleLastPage : 4 RegistrationDate : 2002–10–8 ArticleHistory : OnlineDate : 2002–10–8 ArticleCopyright : BioMed Central Ltd2002 ArticleGrants : ArticleContext : 130593311 David Bruce Email: [email protected] In a move that many will regard as long overdue, the Nobel committee honoured Sydney Brenner with the Nobel Prize for Physiology or Medicine. John Sulston and Robert Horvitz will share the prize, which has been awarded in recognition of the triumvirate's seminal studies on the nematode worm Caenorhabditis elegans. Their discoveries concerning genetic regulation of organ development and programmed cell death have given insights into these processes in many other organisms. In the early 1960s, Sydney Brenner - then at the MRC-LMB in Cambridge and currently a Distinguished Professor at The Salk Institute, California, USA - realized that it would be impossible to use a mammalian system as a tool for studies on cell differentiation and organ development. He identified the nematode Caenorhabditis elegans as an ideal experimental organism because of its short generation time, small cell number (959 cells in the adult) and amenability to examination by both light and electron microscopy. In 1974 he further extended understanding of the worm by showing that ethyl methane sulfonate (EMS) could be used to induce genetic mutations and that these had specific effects on organ development. The worm's amenability to fixation and thin sectioning enabled Brenner to undertake a detailed examination of its nervous system, leading to the publication in 1986 of a complete map of the C.
    [Show full text]